Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry
Emtricitabine (FTC) and tenofovir (TFV) are widely used antiviral agents that require intracellular phosphorylation to become active. This article describes the development and validation of an assay for the simultaneous quantification of FTC mono-, di- and triphosphate (FTC-MP, -DP and -TP), TFV an...
Saved in:
| Published in | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Vol. 878; no. 7; pp. 621 - 627 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Amsterdam
Elsevier B.V
01.03.2010
Elsevier |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1570-0232 1873-376X 1873-376X |
| DOI | 10.1016/j.jchromb.2010.01.002 |
Cover
| Abstract | Emtricitabine (FTC) and tenofovir (TFV) are widely used antiviral agents that require intracellular phosphorylation to become active. This article describes the development and validation of an assay for the simultaneous quantification of FTC mono-, di- and triphosphate (FTC-MP, -DP and -TP), TFV and TFV mono- and diphosphate (TFV-MP and -DP) in peripheral blood mononuclear cells. Reference compounds and internal standards were obtained by thermal degradation of FTC-TP, TFV-DP, stable isotope-labeled TFV-DP and stable isotope-labeled cytosine triphosphate. Cells were lysed in methanol:water (70:30, v/v) and the extracted nucleotides were analyzed using weak anion-exchange chromatography coupled with tandem mass spectrometry. Calibration ranges in PBMC lysate from 0.727 to 36.4, 1.33 to 66.4 and 1.29 to 64.6
nM for FTC-MP, FTC-DP and FTC-TP and from 1.51 to 75.6, 1.54 to 77.2 and 2.54 to 127
nM for TFV, TFV-MP and TFV-DP, respectively, were validated. Accuracies were within −10.3 and 16.7% deviation at the lower limit of quantification at which the coefficients of variation were less than 18.2%. At the other tested levels accuracies were within −14.3 and 9.81% deviation and the coefficients of variation lower than 14.7%. The stability of the compounds was assessed under various analytically relevant conditions. The method was successfully applied to clinical samples. |
|---|---|
| AbstractList | Emtricitabine (FTC) and tenofovir (TFV) are widely used antiviral agents that require intracellular phosphorylation to become active. This article describes the development and validation of an assay for the simultaneous quantification of FTC mono-, di- and triphosphate (FTC-MP, -DP and -TP), TFV and TFV mono- and diphosphate (TFV-MP and -DP) in peripheral blood mononuclear cells. Reference compounds and internal standards were obtained by thermal degradation of FTC-TP, TFV-DP, stable isotope-labeled TFV-DP and stable isotope-labeled cytosine triphosphate. Cells were lysed in methanol:water (70:30, v/v) and the extracted nucleotides were analyzed using weak anion-exchange chromatography coupled with tandem mass spectrometry. Calibration ranges in PBMC lysate from 0.727 to 36.4, 1.33 to 66.4 and 1.29 to 64.6
nM for FTC-MP, FTC-DP and FTC-TP and from 1.51 to 75.6, 1.54 to 77.2 and 2.54 to 127
nM for TFV, TFV-MP and TFV-DP, respectively, were validated. Accuracies were within −10.3 and 16.7% deviation at the lower limit of quantification at which the coefficients of variation were less than 18.2%. At the other tested levels accuracies were within −14.3 and 9.81% deviation and the coefficients of variation lower than 14.7%. The stability of the compounds was assessed under various analytically relevant conditions. The method was successfully applied to clinical samples. Emtricitabine (FTC) and tenofovir (TFV) are widely used antiviral agents that require intracellular phosphorylation to become active. This article describes the development and validation of an assay for the simultaneous quantification of FTC mono-, di- and triphosphate (FTC-MP, -DP and -TP), TFV and TFV mono- and diphosphate (TFV-MP and -DP) in peripheral blood mononuclear cells. Reference compounds and internal standards were obtained by thermal degradation of FTC-TP, TFV-DP, stable isotope-labeled TFV-DP and stable isotope-labeled cytosine triphosphate. Cells were lysed in methanol:water (70:30, v/v) and the extracted nucleotides were analyzed using weak anion-exchange chromatography coupled with tandem mass spectrometry. Calibration ranges in PBMC lysate from 0.727 to 36.4, 1.33 to 66.4 and 1.29 to 64.6 nM for FTC-MP, FTC-DP and FTC-TP and from 1.51 to 75.6, 1.54 to 77.2 and 2.54 to 127 nM for TFV, TFV-MP and TFV-DP, respectively, were validated. Accuracies were within -10.3 and 16.7% deviation at the lower limit of quantification at which the coefficients of variation were less than 18.2%. At the other tested levels accuracies were within -14.3 and 9.81% deviation and the coefficients of variation lower than 14.7%. The stability of the compounds was assessed under various analytically relevant conditions. The method was successfully applied to clinical samples. Emtricitabine (FTC) and tenofovir (TFV) are widely used antiviral agents that require intracellular phosphorylation to become active. This article describes the development and validation of an assay for the simultaneous quantification of FTC mono-, di- and triphosphate (FTC-MP, -DP and -TP), TFV and TFV mono- and diphosphate (TFV-MP and -DP) in peripheral blood mononuclear cells. Reference compounds and internal standards were obtained by thermal degradation of FTC-TP, TFV-DP, stable isotope-labeled TFV-DP and stable isotope-labeled cytosine triphosphate. Cells were lysed in methanol:water (70:30, v/v) and the extracted nucleotides were analyzed using weak anion-exchange chromatography coupled with tandem mass spectrometry. Calibration ranges in PBMC lysate from 0.727 to 36.4, 1.33 to 66.4 and 1.29 to 64.6 nM for FTC-MP, FTC-DP and FTC-TP and from 1.51 to 75.6, 1.54 to 77.2 and 2.54 to 127 nM for TFV, TFV-MP and TFV-DP, respectively, were validated. Accuracies were within -10.3 and 16.7% deviation at the lower limit of quantification at which the coefficients of variation were less than 18.2%. At the other tested levels accuracies were within -14.3 and 9.81% deviation and the coefficients of variation lower than 14.7%. The stability of the compounds was assessed under various analytically relevant conditions. The method was successfully applied to clinical samples.Emtricitabine (FTC) and tenofovir (TFV) are widely used antiviral agents that require intracellular phosphorylation to become active. This article describes the development and validation of an assay for the simultaneous quantification of FTC mono-, di- and triphosphate (FTC-MP, -DP and -TP), TFV and TFV mono- and diphosphate (TFV-MP and -DP) in peripheral blood mononuclear cells. Reference compounds and internal standards were obtained by thermal degradation of FTC-TP, TFV-DP, stable isotope-labeled TFV-DP and stable isotope-labeled cytosine triphosphate. Cells were lysed in methanol:water (70:30, v/v) and the extracted nucleotides were analyzed using weak anion-exchange chromatography coupled with tandem mass spectrometry. Calibration ranges in PBMC lysate from 0.727 to 36.4, 1.33 to 66.4 and 1.29 to 64.6 nM for FTC-MP, FTC-DP and FTC-TP and from 1.51 to 75.6, 1.54 to 77.2 and 2.54 to 127 nM for TFV, TFV-MP and TFV-DP, respectively, were validated. Accuracies were within -10.3 and 16.7% deviation at the lower limit of quantification at which the coefficients of variation were less than 18.2%. At the other tested levels accuracies were within -14.3 and 9.81% deviation and the coefficients of variation lower than 14.7%. The stability of the compounds was assessed under various analytically relevant conditions. The method was successfully applied to clinical samples. |
| Author | Jansen, Robert S. Beijnen, Jos H. Rosing, Hilde Kromdijk, Wiete ter Heine, Rob Schellens, Jan HM |
| Author_xml | – sequence: 1 givenname: Robert S. surname: Jansen fullname: Jansen, Robert S. email: Robert.jansen@slz.nl organization: Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands – sequence: 2 givenname: Hilde surname: Rosing fullname: Rosing, Hilde organization: Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands – sequence: 3 givenname: Wiete surname: Kromdijk fullname: Kromdijk, Wiete organization: Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands – sequence: 4 givenname: Rob surname: ter Heine fullname: ter Heine, Rob organization: Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands – sequence: 5 givenname: Jan HM surname: Schellens fullname: Schellens, Jan HM organization: Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands – sequence: 6 givenname: Jos H. surname: Beijnen fullname: Beijnen, Jos H. organization: Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands |
| BackLink | https://cir.nii.ac.jp/crid/1573387450630208896$$DView record in CiNii http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22807136$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20122883$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFksuKFDEUhgsZcS76CEoWiqtuc6lLGheDDN5gwIUK7kIqOdV92qqkOknN2K_nk5myexDc9CYJ4fvzn5z_XBZnzjsoiueMLhll9Zvtcms2wQ_tktN8R9mSUv6ouGCyEQvR1D_O8rlq6IJywc-Lyxi3lLKGNuJJcZ4lnEspLorfX3GY-qQd-CmS3aRdwg6NTugd8R2BIQU0mHSLDoh2liRwvvN3GIibTA8-oYVI0JERAo4bCLonbe-9JYPPNc-MDsRA30cyRXRrcg_6Z34qOyzgl9lotwbS425CS_5-SSe_Dnrc7Inx09iDJfeYNiQXaWEgg46RxBFMyiiksH9aPO50H-HZcb8qvn94_-3m0-L2y8fPN-9uF6asqrSooWxFQw2wWthW1E1XdbyivLISeJmboWVbctquKlu2JeOiorqVdlUbKpltW3FVvD68Owa_myAmNWCc_3VonmrKqhY1XTWnSSHE3H6ZyRdHcmoHsGoMOOiwVw8BZeDVEdDR6L4L2hmM_zguacNEnbm3B84EH2OATs2hzSmmoLFXjKp5bNRWHcdmtqCKMpXHJqur_9QPBqd0Lw86h5gN5zXPnBAy94LWgnIq5Wou7vqAQY7nDiGoaBCcAYsh56isxxNGfwAjTO8n |
| CitedBy_id | crossref_primary_10_1007_s00216_017_0449_9 crossref_primary_10_1016_j_jpba_2017_08_028 crossref_primary_10_1556_AChrom_27_2015_4_1 crossref_primary_10_1002_dta_3033 crossref_primary_10_2174_1574885514666181217125550 crossref_primary_10_1128_AAC_01693_15 crossref_primary_10_1016_j_jpba_2013_11_010 crossref_primary_10_1016_j_jpba_2015_02_051 crossref_primary_10_1016_j_talanta_2020_121862 crossref_primary_10_1080_10408347_2019_1570462 crossref_primary_10_1149_2_105308jes crossref_primary_10_1016_j_ab_2019_113399 crossref_primary_10_1007_s41061_016_0090_7 crossref_primary_10_1007_s00216_013_6818_0 crossref_primary_10_1016_j_jchromb_2011_07_045 crossref_primary_10_1016_j_antiviral_2015_07_010 crossref_primary_10_3390_ph13110367 crossref_primary_10_1016_j_jpba_2011_05_039 crossref_primary_10_1080_17425255_2018_1500552 crossref_primary_10_1002_jms_1659 crossref_primary_10_1002_prp2_131 crossref_primary_10_1016_j_bioelechem_2018_06_002 |
| Cites_doi | 10.1016/j.jchromb.2006.05.043 10.1128/AAC.00831-06 10.1016/j.jchromb.2006.10.063 10.1002/jms.1133 10.1021/mp900036s 10.1089/aid.2004.20.1173 10.1128/AAC.45.10.2733-2739.2001 10.1177/135965350601100302 10.1128/AAC.43.9.2245 10.1002/jms.500 10.1128/AAC.00138-06 10.1097/01.qai.0000167155.44980.e8 10.1002/jms.1294 10.1177/135965350501000308 10.1002/1097-0231(20000915)14:17<1625::AID-RCM72>3.0.CO;2-0 10.1002/rcm.684 10.1097/01.qai.0000168882.67942.3f 10.1081/NCN-100002567 10.1128/AAC.49.5.1907-1914.2005 10.1002/rcm.3318 |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier B.V. 2015 INIST-CNRS Copyright 2010 Elsevier B.V. All rights reserved. Copyright 2010 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2010 Elsevier B.V. – notice: 2015 INIST-CNRS – notice: Copyright 2010 Elsevier B.V. All rights reserved. – notice: Copyright 2010 Elsevier B.V. All rights reserved. |
| DBID | RYH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 7T5 7T7 7TM 8FD C1K FR3 H94 P64 |
| DOI | 10.1016/j.jchromb.2010.01.002 |
| DatabaseName | CiNii Complete CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Technology Research Database Nucleic Acids Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | Technology Research Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Anatomy & Physiology |
| EISSN | 1873-376X |
| EndPage | 627 |
| ExternalDocumentID | 20122883 22807136 10_1016_j_jchromb_2010_01_002 10028033167 S1570023210000048 |
| Genre | Journal Article |
| GroupedDBID | --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29K 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AARLI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFS ACNNM ACRLP ADBBV ADECG ADEZE ADUVX AEBSH AEFWE AEHWI AEKER AFKWA AFTJW AFXIZ AFZHZ AGHFR AGRDE AGUBO AGYEJ AI. AIEXJ AIKHN AITUG AJBFU AJOXV AJSZI ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 D-I DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FLBIZ FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A NCXOZ O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 RIG RNS ROL RPZ SCB SCC SDF SDG SDP SES SEW SPC SPCBC SSK SSU SSZ T5K VH1 XFK ZGI ~G- AATTM AAXKI AAYWO AEIPS AGCQF AGRNS AIIUN ANKPU RYH SSH AAYXX ACLOT AFJKZ APXCP CITATION EFKBS ~HD BNPGV IQODW CGR CUY CVF ECM EIF NPM 7X8 7T5 7T7 7TM 8FD C1K FR3 H94 P64 |
| ID | FETCH-LOGICAL-c455t-6e4b370ce163db367f5f25025d8e24883a8b420b95d4b412350ab8d96c081dbb3 |
| IEDL.DBID | AIKHN |
| ISSN | 1570-0232 1873-376X |
| IngestDate | Tue Oct 07 09:36:01 EDT 2025 Wed Oct 01 12:49:17 EDT 2025 Thu Apr 03 06:59:42 EDT 2025 Mon Jul 21 09:11:41 EDT 2025 Wed Oct 01 02:30:59 EDT 2025 Thu Apr 24 23:10:37 EDT 2025 Thu Jun 26 23:52:44 EDT 2025 Fri Feb 23 02:37:24 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | Emtricitabine Tenofovir Nucleotides Weak anion-exchange LC–MS Antiretroviral agent RNA-directed DNA polymerase Chemical analysis HPLC chromatography Nucleotide analog Phosphorus Organic compounds Ion exchange chromatography Anion exchange Mononuclear cell Reverse transcriptase inhibitor Nucleoside analog Antiviral Quantitative analysis Purine nucleotide Acyclic nucleotide Enzyme Transferases Enzyme inhibitor Organic phosphonate Nucleotidyltransferases Blood cell LC-MS Simultaneous measurement Anion exchanger Mass spectrometry |
| Language | English |
| License | https://www.elsevier.com/tdm/userlicense/1.0 CC BY 4.0 Copyright 2010 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c455t-6e4b370ce163db367f5f25025d8e24883a8b420b95d4b412350ab8d96c081dbb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 20122883 |
| PQID | 733328838 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_745636097 proquest_miscellaneous_733328838 pubmed_primary_20122883 pascalfrancis_primary_22807136 crossref_citationtrail_10_1016_j_jchromb_2010_01_002 crossref_primary_10_1016_j_jchromb_2010_01_002 nii_cinii_1573387450630208896 elsevier_sciencedirect_doi_10_1016_j_jchromb_2010_01_002 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2010-03-01 |
| PublicationDateYYYYMMDD | 2010-03-01 |
| PublicationDate_xml | – month: 03 year: 2010 text: 2010-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Amsterdam |
| PublicationPlace_xml | – name: Amsterdam – name: Netherlands |
| PublicationTitle | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences |
| PublicationTitleAlternate | J Chromatogr B Analyt Technol Biomed Life Sci |
| PublicationYear | 2010 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Claire (bib8) 2000; 14 Veltkamp, Hillebrand, Rosing, Jansen, Wickremsinhe, Perkins, Schellens, Beijnen (bib18) 2006; 41 Wang, Begley, St, Harris, Wakeford, Rousseau (bib1) 2004; 20 Pruvost, Theodoro, Agrofoglio, Negredo, Benech (bib14) 2008; 43 Durand-Gasselin, Da Silva, Benech, Pruvost, Grassi (bib15) 2007; 51 Back, Burger, Flexner, Gerber (bib5) 2005; 39 Hawkins, Veikley, Claire, Guyer, Clark, Kearney (bib3) 2005; 39 Darque, Valette, Rousseau, Wang, Sommadossi, Zhou (bib6) 1999; 43 Becher, Pruvost, Gale, Couerbe, Goujard, Boutet, Ezan, Grassi, Benech (bib22) 2003; 38 Pruvost, Negredo, Benech, Theodoro, Puig, Grau, Garcia, Molto, Grassi, Clotet (bib16) 2005; 49 Durand-Gasselin, Van Rompay, Vela, Henne, Lee, Rhodes, Ray (bib23) 2009; 6 Shi, Wu, Li, Geleziunas, Gallagher, Emm, Olah, Unger (bib20) 2002; 16 Ray, Myrick, Vela, Olson, Eisenberg, Borroto-Esodo, Miller, Fridland (bib11) 2005; 10 Delaney, Ray, Yang, Qi, Xiong, Zhu, Miller (bib10) 2006; 50 Vela, Olson, Huang, Fridland, Ray (bib24) 2007; 848 Bartley, Begley, Clark (bib9) 2007 Kuklenyik, Martin, Pau, Garcia-Lerma, Heneine, Pirkle, Barr (bib13) 2008 Jansen, Rosing, de Wolf, Beijnen (bib19) 2007; 21 Lynch, Eisenberg, Kernan (bib12) 2001; 20 Barditch-Crovo, Deeks, Collier, Safrin, Coakley, Miller, Kearney, Coleman, Lamy, Kahn, McGowan, Lietman (bib2) 2001; 45 Delinsky, Hernandez-Santiago, Schinazi (bib17) 2006 King, Bushman, Kiser, Anderson, Ray, Delahunty, Fletcher (bib7) 2006; 843 U.S Food and Drug Administration: Centre for Drug Evaluation and Research, Guidance for Industry: Bioanalytical Method Validation, 2001. Borroto-Esoda, Vela, Myrick, Ray, Miller (bib4) 2006; 11 Claire (10.1016/j.jchromb.2010.01.002_bib8) 2000; 14 Lynch (10.1016/j.jchromb.2010.01.002_bib12) 2001; 20 Wang (10.1016/j.jchromb.2010.01.002_bib1) 2004; 20 Veltkamp (10.1016/j.jchromb.2010.01.002_bib18) 2006; 41 Shi (10.1016/j.jchromb.2010.01.002_bib20) 2002; 16 Barditch-Crovo (10.1016/j.jchromb.2010.01.002_bib2) 2001; 45 Jansen (10.1016/j.jchromb.2010.01.002_bib19) 2007; 21 Delinsky (10.1016/j.jchromb.2010.01.002_bib17) 2006 Vela (10.1016/j.jchromb.2010.01.002_bib24) 2007; 848 King (10.1016/j.jchromb.2010.01.002_bib7) 2006; 843 Durand-Gasselin (10.1016/j.jchromb.2010.01.002_bib23) 2009; 6 Pruvost (10.1016/j.jchromb.2010.01.002_bib16) 2005; 49 Hawkins (10.1016/j.jchromb.2010.01.002_bib3) 2005; 39 Durand-Gasselin (10.1016/j.jchromb.2010.01.002_bib15) 2007; 51 Bartley (10.1016/j.jchromb.2010.01.002_bib9) 2007 Delaney (10.1016/j.jchromb.2010.01.002_bib10) 2006; 50 Borroto-Esoda (10.1016/j.jchromb.2010.01.002_bib4) 2006; 11 Ray (10.1016/j.jchromb.2010.01.002_bib11) 2005; 10 Kuklenyik (10.1016/j.jchromb.2010.01.002_bib13) 2008 Darque (10.1016/j.jchromb.2010.01.002_bib6) 1999; 43 Becher (10.1016/j.jchromb.2010.01.002_bib22) 2003; 38 Pruvost (10.1016/j.jchromb.2010.01.002_bib14) 2008; 43 Back (10.1016/j.jchromb.2010.01.002_bib5) 2005; 39 10.1016/j.jchromb.2010.01.002_bib21 |
| References_xml | – volume: 49 start-page: 1907 year: 2005 ident: bib16 publication-title: Antimicrob. Agents Chemother. – volume: 20 start-page: 1415 year: 2001 ident: bib12 publication-title: Nucleosides Nucleotides Nucleic Acids – volume: 848 start-page: 335 year: 2007 ident: bib24 publication-title: J. Chromatogr. B – volume: 45 start-page: 2733 year: 2001 ident: bib2 publication-title: Antimicrob. Agents Chemother. – volume: 21 start-page: 4049 year: 2007 ident: bib19 publication-title: Rapid Commun. Mass Spectrom. – volume: 51 start-page: 2105 year: 2007 ident: bib15 publication-title: Antimicrob. Agents Chemother. – volume: 41 start-page: 1633 year: 2006 ident: bib18 publication-title: J. Mass Spectrom. – volume: 16 start-page: 1092 year: 2002 ident: bib20 publication-title: Rapid Commun. Mass Spectrom. – volume: 843 start-page: 147 year: 2006 ident: bib7 publication-title: J. Chromatogr. B – year: 2008 ident: bib13 publication-title: Proceedings of the 56th ASMS Conference on Mass Spectrometry and Allied Topics – volume: 38 start-page: 879 year: 2003 ident: bib22 publication-title: J. Mass Spectrom. – volume: 43 start-page: 224 year: 2008 ident: bib14 publication-title: J. Mass Spectrom. – year: 2006 ident: bib17 publication-title: Proceedings of the 54th ASMS Conference on Mass Spectrometry and Allied Topics – volume: 20 start-page: 1173 year: 2004 ident: bib1 publication-title: AIDS Res. Hum. Retroviruses – reference: U.S Food and Drug Administration: Centre for Drug Evaluation and Research, Guidance for Industry: Bioanalytical Method Validation, 2001. – volume: 43 start-page: 2245 year: 1999 ident: bib6 publication-title: Antimicrob. Agents Chemother. – volume: 39 start-page: 406 year: 2005 ident: bib3 publication-title: J. Acquir. Immune. Defic. Syndr. – volume: 50 start-page: 2471 year: 2006 ident: bib10 publication-title: Antimicrob. Agents Chemother. – volume: 6 start-page: 1145 year: 2009 ident: bib23 publication-title: Mol. Pharm. – volume: 10 start-page: 451 year: 2005 ident: bib11 publication-title: Antivir. Ther. – volume: 11 start-page: 377 year: 2006 ident: bib4 publication-title: Antivir. Ther. – volume: 39 start-page: S1 year: 2005 ident: bib5 publication-title: J. Acquir. Immune. Defic. Syndr. – volume: 14 start-page: 1625 year: 2000 ident: bib8 publication-title: Rapid Commun. Mass Spectrom. – year: 2007 ident: bib9 publication-title: Proceedings of the 55th ASMS Conference on Mass Spectrometry and Allied Topics – volume: 843 start-page: 147 year: 2006 ident: 10.1016/j.jchromb.2010.01.002_bib7 publication-title: J. Chromatogr. B doi: 10.1016/j.jchromb.2006.05.043 – volume: 51 start-page: 2105 year: 2007 ident: 10.1016/j.jchromb.2010.01.002_bib15 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00831-06 – volume: 848 start-page: 335 year: 2007 ident: 10.1016/j.jchromb.2010.01.002_bib24 publication-title: J. Chromatogr. B doi: 10.1016/j.jchromb.2006.10.063 – volume: 41 start-page: 1633 year: 2006 ident: 10.1016/j.jchromb.2010.01.002_bib18 publication-title: J. Mass Spectrom. doi: 10.1002/jms.1133 – volume: 6 start-page: 1145 year: 2009 ident: 10.1016/j.jchromb.2010.01.002_bib23 publication-title: Mol. Pharm. doi: 10.1021/mp900036s – volume: 20 start-page: 1173 year: 2004 ident: 10.1016/j.jchromb.2010.01.002_bib1 publication-title: AIDS Res. Hum. Retroviruses doi: 10.1089/aid.2004.20.1173 – volume: 45 start-page: 2733 year: 2001 ident: 10.1016/j.jchromb.2010.01.002_bib2 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.45.10.2733-2739.2001 – volume: 11 start-page: 377 year: 2006 ident: 10.1016/j.jchromb.2010.01.002_bib4 publication-title: Antivir. Ther. doi: 10.1177/135965350601100302 – volume: 43 start-page: 2245 year: 1999 ident: 10.1016/j.jchromb.2010.01.002_bib6 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.43.9.2245 – volume: 38 start-page: 879 year: 2003 ident: 10.1016/j.jchromb.2010.01.002_bib22 publication-title: J. Mass Spectrom. doi: 10.1002/jms.500 – volume: 50 start-page: 2471 year: 2006 ident: 10.1016/j.jchromb.2010.01.002_bib10 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.00138-06 – volume: 39 start-page: 406 year: 2005 ident: 10.1016/j.jchromb.2010.01.002_bib3 publication-title: J. Acquir. Immune. Defic. Syndr. doi: 10.1097/01.qai.0000167155.44980.e8 – year: 2008 ident: 10.1016/j.jchromb.2010.01.002_bib13 – volume: 43 start-page: 224 year: 2008 ident: 10.1016/j.jchromb.2010.01.002_bib14 publication-title: J. Mass Spectrom. doi: 10.1002/jms.1294 – volume: 10 start-page: 451 year: 2005 ident: 10.1016/j.jchromb.2010.01.002_bib11 publication-title: Antivir. Ther. doi: 10.1177/135965350501000308 – ident: 10.1016/j.jchromb.2010.01.002_bib21 – year: 2007 ident: 10.1016/j.jchromb.2010.01.002_bib9 – volume: 14 start-page: 1625 year: 2000 ident: 10.1016/j.jchromb.2010.01.002_bib8 publication-title: Rapid Commun. Mass Spectrom. doi: 10.1002/1097-0231(20000915)14:17<1625::AID-RCM72>3.0.CO;2-0 – volume: 16 start-page: 1092 year: 2002 ident: 10.1016/j.jchromb.2010.01.002_bib20 publication-title: Rapid Commun. Mass Spectrom. doi: 10.1002/rcm.684 – volume: 39 start-page: S1 issue: Suppl. 1 year: 2005 ident: 10.1016/j.jchromb.2010.01.002_bib5 publication-title: J. Acquir. Immune. Defic. Syndr. doi: 10.1097/01.qai.0000168882.67942.3f – volume: 20 start-page: 1415 year: 2001 ident: 10.1016/j.jchromb.2010.01.002_bib12 publication-title: Nucleosides Nucleotides Nucleic Acids doi: 10.1081/NCN-100002567 – volume: 49 start-page: 1907 year: 2005 ident: 10.1016/j.jchromb.2010.01.002_bib16 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.49.5.1907-1914.2005 – volume: 21 start-page: 4049 year: 2007 ident: 10.1016/j.jchromb.2010.01.002_bib19 publication-title: Rapid Commun. Mass Spectrom. doi: 10.1002/rcm.3318 – year: 2006 ident: 10.1016/j.jchromb.2010.01.002_bib17 |
| SSID | ssj0017073 |
| Score | 2.068223 |
| Snippet | Emtricitabine (FTC) and tenofovir (TFV) are widely used antiviral agents that require intracellular phosphorylation to become active. This article describes... |
| SourceID | proquest pubmed pascalfrancis crossref nii elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 621 |
| SubjectTerms | Adenine - analogs & derivatives Adenine - blood Adenine Nucleotides - blood Analysis Analytical, structural and metabolic biochemistry Anions - chemistry Biological and medical sciences Chromatography, Ion Exchange - methods Deoxycytidine - analogs & derivatives Deoxycytidine - blood Drug Stability Emtricitabine Fundamental and applied biological sciences. Psychology General pharmacology Humans LC-MS Leukocytes, Mononuclear - chemistry Linear Models Medical sciences Nucleotides Nucleotides - blood Organophosphonates - blood Pharmacology. Drug treatments Phosphorylation Pyrimidine Nucleotides - blood Reproducibility of Results Tandem Mass Spectrometry - methods Tenofovir Weak anion-exchange |
| Title | Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry |
| URI | https://dx.doi.org/10.1016/j.jchromb.2010.01.002 https://cir.nii.ac.jp/crid/1573387450630208896 https://www.ncbi.nlm.nih.gov/pubmed/20122883 https://www.proquest.com/docview/733328838 https://www.proquest.com/docview/745636097 |
| Volume | 878 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Complete Freedom Collection [SCCMFC] customDbUrl: eissn: 1873-376X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017073 issn: 1570-0232 databaseCode: ACRLP dateStart: 20020105 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection customDbUrl: eissn: 1873-376X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017073 issn: 1570-0232 databaseCode: .~1 dateStart: 20020105 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals [SCFCJ] customDbUrl: eissn: 1873-376X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017073 issn: 1570-0232 databaseCode: AIKHN dateStart: 20020105 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELa23QsXBCyPAlvNAXFLm_fjWFWsymuFWFbaW2THDrg0SbdNgb3w4_hlzNhJVysBK3HJobId1zOxP9vffMPYixKXHcQB0sncAjcohSucrCykE0uZ8cjjfmLykL0_jRfn4ZuL6OKAzftYGKJVdnO_ndPNbN39Mu1Gc7rWenrmkTS7TzEoBuimA3aI60-aDtnh7PXbxen-MiFxzUUzlXeownUgz3Q5WRZfNk0lOpKXtz9g-cMSNai1Ju4k3-LwlTbvxd-BqVmgTu6xux2yhJnt_H12oOoH7GhW4666uoKXYLie5hD9iP0608Qk5LXCjT9c7rilDBkrQVOCqki4X7cc980KeC0BoXVTNt_0BmpSQG5aLdUWdA2klGykCVZgSPCAft2YMnwDdC2wBeLWf4bvin_FpvANjvph441hpS93WoIZHOynVc-GotmtV0oCnREDHXWoCioE-WDCQklfod1cPWTnJ68-zRdOl83BKcIoap1YhSJI3EIhApQiiJMyKhF_-ZFMlY_TSMBTEfquyCIZipBCeF0uUpnFBaIWKUTwiA2x_-oJg0D6Soo4ybirwhKdqhRYqEw4afuHqTdiYW_AvOikzinjxirvOW3LvLN7TnbPXS9Hu4_YZF9tbbU-bquQ9t6R33DaHNej26oeozdh7-jpkSgl5R0gATSfiGfxiI1v-Nm-Q0a-yAuwAPSOl-OMQPa0TpNjWwHlkE7_UQRhcxC7WTJij63PXrdPd61Y--n__7dn7I7lWBBT7zkbtpudOkbo1ooxG0x-emP8QOcf330Ydx_qb-7ySJI |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELbacoALAsojQMscELdN9v04VhVVgLaXtlJvlr22wSG7m242QC_8OH4ZM95NqkpAJS45ROON1zOxP9vffMPYW4PLDuIA5RV-iRuU0pdeYUrlpUoVIglEmLk6ZCen6fQi_niZXG6xw3UuDNEqh7m_n9PdbD18MxlGc7KwdnIWkDR7SDkoDujm2-xenIQZ7cDGPzc8jyDz3TUzWXtkfpPGM5mNZ-WXtqnkQPEKNscrf1igtmtriTkpljh4pq968XdY6pano0fs4YAr4aDv-mO2pesnbPegxj11dQ3vwDE93RH6Lvt1ZolHKGqN2364WomeMOR8BI0BXZFsv-0E7po1iFoBAuvGNN9sCzXpHzedVXoJtgbSSXbCBHNwFHjAqG6cjWiBLgWWQMz6z_Bdi6_4KPwFT__os41hbq9WVoEbHOxnr50NZbNazLUCOiEGOujQFVQI8cElhZK6QtdeP2UXR-_PD6feUMvBK-Mk6bxUxzLK_FIj_lMySjOTGERfYaJyHeIkEolcxqEvi0TFMqYEXl_IXBVpiZhFSRk9YzvYf_2CQaRCrWSaFcLXscGQMhKNTCZI2T_OgxGL1w7k5SB0TvU25nzNaJvxwe-c_M79gKPfR2y8abbolT7uapCvo4PfClmOq9FdTfcwmrB39BmQJCVVHSD5s5BoZ-mI7d-Ks02HnHhREKEBrAOP43xA_uyDhuOzIqognf_DBEFzlPpFNmLP-5i9eT7dtGLrl___bm_Y_en5yTE__nD66RV70LMtiLP3mu107UrvIYjr5L77k_4GfNhHxQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Simultaneous+quantification+of+emtricitabine+and+tenofovir+nucleotides+in+peripheral+blood+mononuclear+cells+using+weak+anion-exchange+liquid+chromatography+coupled+with+tandem+mass+spectrometry&rft.jtitle=Journal+of+chromatography.+B%2C+Analytical+technologies+in+the+biomedical+and+life+sciences&rft.au=Jansen%2C+Robert+S.&rft.au=Rosing%2C+Hilde&rft.au=Kromdijk%2C+Wiete&rft.au=ter+Heine%2C+Rob&rft.date=2010-03-01&rft.issn=1570-0232&rft.volume=878&rft.issue=7-8&rft.spage=621&rft.epage=627&rft_id=info:doi/10.1016%2Fj.jchromb.2010.01.002&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jchromb_2010_01_002 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1570-0232&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1570-0232&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1570-0232&client=summon |